miR-665 Suppresses the Epithelial-Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1.
Kun-Zhe WuChun-Dong ZhangCheng ZhangJun-Peng PeiDong-Qiu DaiPublished in: Cancer management and research (2020)
The overall study results demonstrated that miR-665 inhibits tumor progression and EMT in GC by targeting CRIM1, indicating that miR-665 might be a potential therapeutic target in the treatment of GC patients.
Keyphrases
- epithelial mesenchymal transition
- cell proliferation
- long non coding rna
- long noncoding rna
- end stage renal disease
- poor prognosis
- signaling pathway
- ejection fraction
- chronic kidney disease
- newly diagnosed
- transforming growth factor
- prognostic factors
- peritoneal dialysis
- risk assessment
- mass spectrometry
- combination therapy
- patient reported
- replacement therapy